Preliminary results of 90Y and 177Lu radiolabelling of ultra small rigid particles as multimodal probes

被引：0
|
作者：
Maurin, Michal [1 ]
Garnuszek, Piotr [1 ]
Mikolajczak, Renata [1 ]
Truillet, Charles [2 ]
Lux, F. [2 ]
Clabaut, A. [2 ]
Tillement, Oilivier [2 ]
机构：
[1] Radioisotope Ctr POLATOM NCBJ, Res Dept, Otwock, Poland
[2] Univ Lyon 1, CNRS, Lab Physicochim Mat Luminescents, Lyon, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P150
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [31] Optimized cocktail of 90Y/177Lu for radionuclide therapy of neuroendocrine tumors of various sizes: a simulation study
    Peer-Firozjaei, Milad
    Tajik-Mansoury, Mohammad Ali
    Geramifar, Parham
    Ghorbani, Raheb
    Zarifi, Shiva
    Miller, Cassandra
    Rahmim, Arman
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 646 - 655
  • [32] COSTBM0607-WG2, Preparation of therapeutic doses of 177Lu or 90Y DOTATATE for PRRT
    Pawlak, Dariusz
    Wojdowska, Wioletta
    Mikolajczak, Renata
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 723 - 723
  • [33] Production of glass microspheres comprising 90Y and 177Lu for treating of hepatic tumors with SPECT imaging capabilities
    Poorbaygi, Hosein
    Aghamiri, Seyed Mahmoud Reza
    Sheibani, Shahab
    Kamali-asl, Alireza
    Mohagheghpoor, Elham
    APPLIED RADIATION AND ISOTOPES, 2011, 69 (10) : 1407 - 1414
  • [34] Investigation of the influence of metallic impurities on the 90Y and 177Lu labelling yield of DOTA and DOTA-TATE
    Pawlak, D
    Korsak, A
    Mikolajczak, R
    Sasinowska, I
    Parus, JL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S388 - S388
  • [35] 90Y and 177LU labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy
    Liu, S
    Cheung, E
    Ziegler, MC
    Rajopadhye, M
    Edwards, DS
    BIOCONJUGATE CHEMISTRY, 2001, 12 (04) : 559 - 568
  • [36] Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using 90Y or 177Lu
    Kang, Chi Soo
    Chen, Yunwei
    Lee, Hyunbeom
    Liu, Dijie
    Sun, Xiang
    Kweon, Junghun
    Lewis, Michael R.
    Chong, Hyun-Soon
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (03) : 242 - 249
  • [37] Clinical peptide receptor radionuclide therapy: Kit preparation of 90Y, 177Lu, and 111In DOTATATE
    Ballinger, J. R.
    Tan, Y.
    Allen, S. J.
    Lewington, V. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S425 - S425
  • [38] Synthesis and Preclinical Evaluation of Bifunctional Ligands for Improved Chelation Chemistry of 90Y and 177Lu for Targeted Radioimmunotherapy
    Kang, Chi Soo
    Sun, Xiang
    Jia, Fang
    Song, Hyun A.
    Chen, Yunwei
    Lewis, Michael
    Chong, Hyun-Soon
    BIOCONJUGATE CHEMISTRY, 2012, 23 (09) : 1775 - 1782
  • [39] Dual-Isotope Peptide Receptor Radionuclide Therapies with 177Lu and 90Y: Is Quantitative Imaging Possible?
    Miller, C.
    Rahmim, A.
    Celler, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S825 - S825
  • [40] Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE-A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Dmochowska, Beata
    Kapusta, Waldemar
    Zmudzki, Wawrzyniec
    Mroz, Adrianna
    Kos-Kudla, Beata
    Kaminski, Grzegorz
    CANCERS, 2023, 15 (22)
12345